Risk Stratification of Patients Presenting With Upper Gastrointestinal Bleeding to the Emergency Department Using AIMS65 Score and Red Cell Distribution Width
RUGBE
2 other identifiers
observational
348
1 country
1
Brief Summary
The rationale of this study in UGIB patients is to assess whether the prediction of mortality and morbidity using AIMS65 score improves when used in combination with RDW in the emergency department setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2020
CompletedFirst Submitted
Initial submission to the registry
March 29, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedApril 1, 2021
March 1, 2021
1.7 years
March 29, 2021
March 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
predictive accuracy of addition of RDW to AIMS65 SCORE in determining the 30-day mortality of patients presenting to the ED with symptoms of UGIB
30 days
Interventions
Risk Statification of patients presenting with upper gastrointestinal bleeding to the emergency department using AIMS65 score and Red cell Distribution Width.
Eligibility Criteria
All adult (\>18 years of age) patients presenting with UGIB to the ED of Jubilee Mission Medical College and Research Institute during the 18 months' time period were included in the study. The diagnosis of UGIB was based on patients' presentations, including coffee ground vomitus, hematemesis, melena, and blood in nasogastric aspirate. These patients were considered eligible for the study.
You may qualify if:
- All patients presenting to ED with UGIB
- Age more than 18 years of age
You may not qualify if:
- Patients not consenting to study
- Patients with known hematological disorders
- Patients in which endoscopy or blood transfusion is done outside
- Patients in which RDW value and laboratory parameters required for AIMS65 score are not available.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jubilee Mission Medical College and Research Institute
Thrissur, Kerala, 680027, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Siju V Abraham, MD
Jubilee Mission Medical College
- STUDY DIRECTOR
Rajeev P C, MD
Jubilee Mission Medical College
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Junior Resident
Study Record Dates
First Submitted
March 29, 2021
First Posted
April 1, 2021
Study Start
August 1, 2018
Primary Completion
March 31, 2020
Study Completion
October 31, 2020
Last Updated
April 1, 2021
Record last verified: 2021-03